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Heterologous expression of the avirulence gene
ACE1 from the fungal rice pathogen Magnaporthe
oryzae†
Zhongshu Song,‡a Walid Bakeer,‡ab James W. Marshall,a Ahmed A. Yakasai,a
Rozida Mohd Khalid,a Jerome Collemare,c Elizabeth Skellam,d Didier Tharreau,e
Marc-Henri Lebrun,fg Colin M. Lazarus,h Andrew M. Bailey,h Thomas J. Simpsona
and Russell J. Cox*ad
The ACE1 and RAP1 genes from the avirulence signalling gene cluster of the rice blast fungusMagnaporthe
oryzae were expressed in Aspergillus oryzae and M. oryzae itself. Expression of ACE1 alone produced a
polyenyl pyrone (magnaporthepyrone), which is regioselectively epoxidised and hydrolysed to give
diﬀerent diols, 6 and 7, in the two host organisms. Analysis of the three introns present in ACE1
determined that A. oryzae does not process intron 2 correctly, while M. oryzae processes all introns
correctly in both appressoria and mycelia. Co-expression of ACE1 and RAP1 in A. oryzae produced an
amide 8 which is similar to the PKS-NRPS derived backbone of the cytochalasans. Biological testing on
rice leaves showed that neither the diols 6 and 7, nor amide 8 was responsible for the observed ACE1
mediated avirulence, however, gene cluster analysis suggests that the true avirulence signalling
compound may be a tyrosine-derived cytochalasan compound.
Introduction
The rice blast fungus Magnaporthe oryzae, which causes signif-
icant reductions in rice yields,1 is a well-known model for
studying plant fungal interactions and pathogenicity.2 Rice
resistance receptors (R) recognize M. oryzae secreted avirulence
signals (AVR), allowing the rice plant to mount an eﬀective
defence response, killing or containing the fungus within the
initial infected cell. Genetic and molecular studies have
conclusively linked the avirulent phenotype of strain Guy11 on
rice cultivars carrying the resistance gene Pi33, to the presence
of the ACE1 gene (Avirulence Conferring Enzyme).3,4 Unlike the
majority of known AVR genes which encode small secreted
proteins acting directly on the host plant,5 ACE1 encodes a
cytoplasmic biosynthetic protein responsible for the production
of a low molecular weight compound.4
ACE1 belongs to an infection-specic secondary metabolite
gene cluster (Scheme 1),6 expressed only during appressorium-
mediated penetration, and not at any other stage of the M.
oryzae life cycle.7 The 12.4 kb ACE1 gene encodes an enzyme
consisting of a fungal highly-reducing polyketide synthase
(hrPKS)8 fused to a single module of a nonribosomal peptide
synthetase (NRPS).4 Similar fungal synthetases have been
investigated genetically and biochemically and are known to
produce acyl tetramic acids or pyrrolidones including pre-
tenellin A 1,9 prefusarin C 2 (ref. 10) and preaspyridone A 3 (ref.
11 and 12) as well as other potent bioactive compounds
including cytochalasin K 4 (ref. 13 and 14) and the important
cholesterol biosynthesis inhibitor lovastatin 5 (ref. 15) (Scheme
1). It appears likely, therefore, that ACE1 encodes a biosynthetic
protein which makes a small molecule consisting of a polyke-
tide fused to an amino acid. Because ACE1 is under very tight
temporal and cell type-specic control in M. oryzae, it has not
yet been possible to identify or purify the avirulence compound.
Knowledge of the ACE1 metabolite structure would be highly
useful for investigating avirulence signalling and developing
novel resistant cultivars. The research of our group and that of
others has focused on the heterologous expression of other
fungal PKS-NRPS genes in Aspergillus oryzae from gene clusters
of known function.12,16–19 Here we set out to use heterologous
expression of genes from a cryptic pathway to determine its
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unknown chemical product, since knowledge of the ACE1
compound will enhance eﬀorts to design new compounds of
high potential utility in crop protection.
Results
In initial experiments a construct known to express ACE1 in
M. oryzae, containing ACE1 fused to eGFP at its 30 terminus
(pPACE1$ACE1eGFP$hyg),4 was used to construct the vector
pPamyB$ACE1eGFP$argB (Fig. 1A) in which the ACE1-eGFP gene
fusion was located downstream of PamyB.
This plasmid was then used to transform A. oryzae M-2-3.
Transformants were selected on minimal medium and 100
colonies were selected and grown further on both minimal
medium and minimal medium plus maltose. Four trans-
formants showed weak uorescence and these were picked
together with 10 non-uorescent transformants and grown in
liquid medium (see ESI†). The resultant organic extracts were
examined by LCMS but no signicant chemical diﬀerences were
observed between extracts from any of the transformants and
the untransformed A. oryzae M-2-3 strain (data not shown).
Intron processing
Since A. oryzae is increasingly being used as a heterologous host
for studying gene expression, we wanted to determine why our
initial attempt at expressing ACE1 had failed. The ACE1 gene
contains three introns located between exons corresponding to
PKS domains (Fig. 1B). As there is a possibility that A. oryzae
may not always splice heterologously expressed genes the same
way as the host organism,18,20 we explored how the introns of
ACE1 are processed by A. oryzae and M. oryzae.
Each ACE1 intron was amplied with ca. 20 bp of anking 50
and 30 exon sequences and cloned as in-frame fusions with eGFP
downstream of either the native ACE1 promoter (PAce1), the
strong constitutive promoter PgpdA from Aspergillus nidulans or
the inducible promoter PamyB from A. oryzae. A total of nine
plasmids were constructed (Fig. 1C). These constructs were
transformed into either A. oryzae or M. oryzae, along with
positive and negative controls, selected on the appropriate
selection media and observed for uorescence (Table 1 and
Fig. 2). RT-PCR was performed for each intron construct using
primers located either side of the introns and the products were
sequenced (see ESI† for details).
The results demonstrated that introns 1 and 3 are spliced
identically in A. oryzae and M. oryzae whereas incorrect splicing
of intron 2 by A. oryzae results in a frameshi and premature
stop codon (Fig. S1†).
Heterologous expression of ACE1
Based on results from the intron processing experiments, we
created two modied expression plasmids for further attempts
to produce the ACE1 compound (Fig. 1A). The rst consisted of
the entire ACE1 gene lacking all introns fused to eGFP
(pPamyB$ACE1[Dintrons1–3]eGFP$argB); the second consisted
only of the PKS encoding portion of ACE1 – also fused to eGFP,
and containing only intron-3 (pAmyB$ACE1pks[Dintrons1–2]
eGFP$argB, see ESI† for construction details). Controls included
empty vector and eGFP alone (pPgpdA$eGFP$hyg, Fig. 1D).
These plasmids were used to transform A. oryzae M-2-3 and
selection was achieved onminimal medium supplemented with
hygromycin where appropriate. On malt extract agar (MEA) the
transformants containing the ACE1 constructs produced a
bright yellow colour, while the controls were colourless. Twenty
colonies were selected for each construct, grown in liquid
medium and extracted as described above. All transformants
tested clearly produced a new peak compared to the controls
(Fig. 3A) in the neutral organic extract, and in lesser amounts, in
the acidic and mycelial extracts.
The new compounds appeared to be identical for the two
ACE1 expression constructs (RT ¼ 33.2 min; uv max ¼ 214, 272,
Scheme 1 Relationship between biosynthetic gene clusters and the
structures of known compounds in various fungi (only partial gene
clusters are shown). The ACE1 gene cluster (MGG_08381 –
MGG_08391, MGG_12447)6 is shown and the ACE1/RAP1 gene pair
which show signiﬁcant homology to other genes known to produce
bioactive compounds are highlighted. The top panel shows key
chemical steps catalysed by the fungal PKS-NRPS TENS, which syn-
thesises pretenellin A 1 in partnership with the trans-acting ER TENC.
KS, b-ketoacyl synthase; AT, acyl transferase, DH, dehydratase; ER,
enoyl reductase; ERO, defective enoyl reductase; CMeT, C-methyl
transferase; KR, b-ketoacyl reductase; ACP, acyl carrier protein; C,
condensation; A, adenylation; T, thiolation; DKC, Dieckmann cyclase;
R, thiolester reductase.
4838 | Chem. Sci., 2015, 6, 4837–4845 This journal is © The Royal Society of Chemistry 2015
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361 nm; m/z ¼ 315 [M]Na+, 293 [M]H+, 275 [M  H2O]H+). Both
compounds were puried and shown to be identical by NMR
and HRMS (m/z 291.1238 Da [M  H], consistent with a
molecular formula of C16H20O5).
1H NMR analysis (see ESI†) showed that the sample con-
sisted of a 1 : 1 mixture of diastereomers each of which con-
tained three methyl groups, a CHX, ve contiguous olenic
protons, and two sharp doublets (J ¼ 2.0 Hz) in the olenic
region. COSY correlations were used to determine that the
olenic protons were part of a distinct spin-system with an
olenic methyl group, connected by a vicinal coupling, visible
only as a slight broadening of the terminal olen doublet in the
1D 1H NMR. The COSY also showed that the CHX (which
appeared as a complex multiplet) and one of the methyl groups
(itself appearing as a pair of doublets) formed another distinct
coupling system. An HMBC spectrum determined that the lone
methyl group and olens were all part of the same chain with a
formula of C11H17O2, leaving C5H3O3 unaccounted for. The
characteristic 13C NMR resonance of d 163.6 ppm revealed that
an ester group was present in the structure accounting for a
further CO2, and leaving C4H3O unassigned.
The remaining two unassigned protons showed HMBC
correlations to the ester carbonyl and two other quaternary
carbons, the chemical shis of which (d 162.4 ppm and d 162.6
ppm) were consistent with enolic carbons. Although these
protons were coupled, they did not appear to be on adjacent
Fig. 1 Diagrammatic representation of fungal expression systems used in this work (not to scale). Introns indicated by grey bars. PKS-NRPS
functional domains as described in the legend to Scheme 1. P¼ promoter, T¼ terminator. (A) cassettes used for expression of ACE1 and RAP1; (B)
relative positions of ACE1 introns in cDNA and mRNA; (C) cassettes used for testing intron splicing, I ¼ 1/2/3; (D) cassettes used for promoter
testing and coexpression of RAP1.
Table 1 Results of the ACE1 intron processing constructs. Conditions: M, mycelia grown in vitro; A, apressoria grown on cellophane
Construct name Expression host Conditions Fluorescent transformants
pPamyB$intron1$eGFP$argB A. oryzae M 80%
pPamyB$intron2$eGFP$argB A. oryzae M 0%
pPamyB$intron3$eGFP$argB A. oryzae M 90% (Fig. 2A)
Empty vector A. oryzae M 0%
eGFP A. oryzae M 87%
pPgpdA$intron1eGFP$hyg M. oryzae M, A >70%
pPgpdA$intron2eGFP$hyg M. oryzae M, A >70% (Fig. 2B)
pPgpdA$intron3eGFP$hyg M. oryzae M, A >70%
Empty vector M. oryzae M, A 0%
eGFP M. oryzae A >70%
pPACE1$intron1eGFP$hyg M. oryzae A >60% (Fig. 2C)
pPACE1$intron2eGFP$hyg M. oryzae A >60% (Fig. 2D)
pPACE1$intron3eGFP$hyg M. oryzae A >60% (Fig. 2E)
Empty vector M. oryzae M 0%
eGFP M. oryzae M, A >60%
This journal is © The Royal Society of Chemistry 2015 Chem. Sci., 2015, 6, 4837–4845 | 4839
Edge Article Chemical Science
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
1 
Ju
ne
 2
01
5.
 D
ow
nl
oa
de
d 
on
 2
7/
05
/2
01
6 
15
:5
4:
05
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
carbons. An IR spectrum showed a characteristic absorbance at
1685 cm1 suggesting that the ester group was present as part of
a pyrone. Thus the structure was determined as the novel
pyrone 6 to which we have assigned the name 12,13-
dihydroxymagnaporthepyrone.
The polyketide origin of 6 was conrmed by feeding
[1,2-13C2]-acetate and [methyl-
13C]-methionine to A. oryzae
pPamyB$ACE1[Dintrons1–3]eGFP$argB. Pyrone 6 isolated aer
the labelled acetate feed showed the presence of distinctive
doublets in the 13C NMR indicative of the incorporation of
intact 13C2 units (Fig. 4 and ESI†). Matching of the
2JCC values
showed intact acetate incorporations consistent with the hep-
taketide origin of 6. The origin of both methyls from methio-
nine was conrmed by the observation of a 9.4% incorporation
of label at C-15 and C-16.
Thus 6 consists entirely of a polyketide and does not contain
the expected amino acid component. To rule out NRPS per-
turbance by the C-terminal eGFP fusion we modied the
expression system to remove the 30-eGFP gene to create pPa-
myB$ACE1[Dintrons1–3]$argB and transformed A. oryzaeM-2-3.
Selected transformants were grown in liquid medium and
secondary metabolites detected using LCMS; 12,13-dihydrox-
ymagnaporthepyrone 6 was the only new compound detected.
To overcome the possibility that A. oryzae lacks the specic
amino acid required by the ACE1 NRPS in M. oryzae we
constructed plasmids for homologous expression of ACE1 in
M. oryzae Guy11 using the PgpdA constitutive promoter and
hygromycin selection. We thus constructed an E. coli shuttle
vector based on the pUC18 vector with a Gateway cassette
downstream from PgpdA carrying a hygromycin resistance
marker. The ACE1 eGFP construct was transferred into
this vector by Gateway LR recombination in vitro to give
pPgpdA$ACE1eGFP$hyg which was used to transform M. oryzae
Guy11. The plasmid pPgpdA$eGFP$hyg was used as a control.
Hygromyin resistant transformants were selected for each
construct and grown on complete medium plates and examined
for uorescence. For pPgpdA$eGFP$hyg, 18/20 transformants
were uorescent while only 5/100 of the pPgpdA$ACE1eGFP$hyg
transformants were uorescent.
The ve M. oryzae transformants expressing ACE1eGFP were
then grown in complete liquid medium for 7 days then extrac-
ted and examined by LCMS as described in the ESI.† All ve
transformants produced a new compound which was not
produced by the controls. This compound had a diﬀerent
retention time to 12,13 dihydroxymagnaporthepyrone 6
produced in A. oryzae (RT ¼ 31.6 min, Fig. 3B) and a diﬀerent
UV spectrum (uvmax ¼ 210 nm, 248 nm, 340 nm) although the
low resolution ESI MS spectrum was identical to 6, as was the
molecular formula predicted from the HRMS. Thus it appeared
that this compound was isomeric to 12,13-dihydroxy-
magnaporthepyrone 6. 1H NMR showed it to consist of a single
stereoisomer, but compared to 6 it had only three contiguous
olenic CH resonances, one of which was coupled to a CHO
methine which was in turn coupled to another CHO methine.
The methyl doublet of 6 was replaced by a methyl doublet
coupling to an olenic CH. These data, supported by 13C and 2D
spectra showed this compound to be 10,11-dihydrox-
ymagnaporthepyrone 7.
Co-expression with the RAP1 trans-ER protein
Bioinformatic analysis of the sequence of the ACE1 enoyl
reductase (ER) domain suggests that it is inactive, similar to the
tenellin and lovastatin nonaketide synthase (LNKS) ERs – such
domains are designated ER0 to indicate their non-catalytic role.
Many fungal hrPKS which contain an ER0 domain recruit a
trans-acting ER which has a catalytic and programming role. For
example in the cases of pretenellin A 1, preaspyridone 3 and
lovastatin 5 biosynthesis trans-acting ERs encoded by tenC,
Fig. 2 UV-stimulated green ﬂuorescence of intron-eGFP clones. (A) A.
oryzae M-2-3 pPamyB$intron3eGFP$argB; (B) M. oryzae Guy11
pPgpdA$intron2eGFP$hyg; (C) M. oryzae Guy11 pPACE1$intron-
1eGFP$hyg; (D) M. oryzae Guy11 pPACE1$intron2eGFP$hyg; (E) M.
oryzae Guy11 pPACE1$intron3eGFP$hyg. A and B mycelia grown in
liquid; C, D and E appressoria grown on cellophane.
Fig. 3 Diode array chromatograms of culture extracts from: (A) A.
oryzae M-2-3 pPamyB$ACE1[Dintrons1–3]eGFP$argB; (B) M. oryzae
pPgpdA$ACE1[Dintrons1–2]eGFP$hyg; (C) A. oryzae M-2-3 empty
vector transformant.
Fig. 4 Structures and biosynthetic origin of the pyrones obtained by
expressing ACE1 in A. oryzae M-2-3 and M. oryzae.
4840 | Chem. Sci., 2015, 6, 4837–4845 This journal is © The Royal Society of Chemistry 2015
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apdC and lovC respectively interact with the PKS to provide
programmed enoyl reduction and have the eﬀect of reinforcing
PKS programming including methylation and chain-length
delity.15 RAP1 also encodes a trans-acting ER (e.g. RAP1 has a
48% similarity to TENC and 58% similarity to LOVC) and thus it
may play a similar role in concert with ACE1, possibly control-
ling delity as well as enoyl reduction. We therefore constructed
plasmids to coexpress RAP1 with ACE1 in both A. oryzae and M.
oryzae.
For A. oryzae we created a plasmid carrying both the ACE1
and RAP1 genes in which ACE1 lacking all introns was expressed
under the control of PamyB, and RAP1 was expressed from the
strong constitutive alcohol dehydrogenase promoter Padh from
A. oryzae (pPamyB$ACE1[Dintrons 1–3]$argB$Padh$RAP1,
Fig. 1A). A. oryzae M-2-3 protoplasts were transformed with
pPamyB$ACE1[Dintrons 1–3]$argB$Padh$RAP1 and trans-
formants were selected on minimal medium.
Twenty seven of the resulting A. oryzae transformants were
selected and transferred to new agar plates. Ten of these
transformants were grown in liquid medium containing starch
for seven days, then extracted in the usual way. LCMS analysis of
the extracts showed that of the A. oryzae transformants, ve
produced a new peak compared to the controls in the neutral
organic extract, and in lesser amounts, in the acidic and
mycelial extracts. The new compound had diﬀerent retention
times to compounds 6 and 7 (RT ¼ 22.5 min, uv max ¼ 270, 280
nm, m/z 481.4 [M  H] (Fig. 5)).
A single A. oryzae transformant was grown at large scale (800
mL) to yield 65.5 mg of crude extract. The new compound was
puried by HPLC and analysed by NMR and HRMS (m/z
482.3265 Da [M]H+, consistent with a molecular formula of
C30H43NO4).
1H NMR analysis showed that the compound
contained four methyl groups, six olenic protons and an
aromatic group indicative of tyrosine. 13C NMR, COSY, HMBC
and HSQC determined the structure as 8 (Fig. 6, ESI†).
Biological testing
Puried magnaporthepyrones 6 and 7 were tested for biological
activity on susceptible, (Maratelli, Sariceltik CO39) and resistant
rice cultivars carrying Pi33 (IR64 and C101LAC).21 Compounds
were deposited onto normal or wounded rice leaves. Both
compounds induced localised brown necrosis on all cultivars,
irrespective of host genotype (Fig. 7). These results suggest that
magnaporthepyrones do not induce a phenotype specically on
rice cultivars carrying Pi33. Addition of these compounds to
spore suspensions of an isolate virulent on Pi33 rice cultivars
did not induce an AVR reaction, but slightly reduced pathoge-
nicity on both susceptible and resistant cultivars. Compound 8
had no biological activity: no induction of leaf symptoms, no
changes of a virulent interaction into AVR, no enhancement nor
reduction in pathogenicity. Therefore compounds, 6, 7 and 8 do
not appear to be the avirulence signal compound produced by
ACE1/M. oryzae Guy11 during appressorium-mediated
penetration.
Fig. 5 LCMS analysis of ACE1 + RAP1 expression: A, EIC (ES) m/z
480.4 for A. oryzaeM-2-3; B, EIC (ES)m/z 480.4 for A. oryzaeM-2-3
+ ACE1 + RAP1; C, uv chromatogram (280 nm) for A. oryzaeM-2-3; D,
uv chromatogram (280 nm) for A. oryzae M-2-3 + ACE1 + RAP1.
Fig. 6 Structure and NMR data of 8 from ACE1 + RAP1 expression
transformants.
Fig. 7 Biological testing of 12,13-dihydroxymagnaporthepyrone 6 on
both resistant (IR64 and C101LAC) and susceptible (Maratelli) rice
cultivars. Testing of 7 gave similar results. 8 Had no eﬀect.
This journal is © The Royal Society of Chemistry 2015 Chem. Sci., 2015, 6, 4837–4845 | 4841
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Discussion
Initial attempts to express ACE1 in A. oryzae produced no
observable new metabolites. This was surprising as all of our
previous eﬀorts to express foreign fungal genes in this organism
had been successful.
Further investigation using RT-PCR and subsequent
sequence analysis clearly showed that ACE1 intron-2 is not
spliced correctly in A. oryzae, resulting in an mRNA with a
frame-shi and premature stop codon. Intron-2 is located
centrally in the PKS portion of ACE1, upstream of the sequence
encoding the key acyl carrier protein (ACP) domain. Any trun-
cated ACE1 protein resulting from the translation of this
incorrectly spliced mRNA would not be capable of producing a
polyketide product.
Removal of the ACE1 introns resulted in transcripts which
were translated correctly in A. oryzae. Indeed more than 75% of
transformants produced full-length ACE1-eGFP protein fusions
as evidenced by strong uorescence of transformed hyphae, and
the production of novel metabolites. Expression of both full-
length and NRPS-deleted ACE1 intronless constructs resulted in
the production of the same compound, 12,13-dihydroxy-
magnaporthepyrone 6 which is exclusively of polyketide origin
as shown by isotopic labelling. Expression of the same clones in
M. oryzae resulted in the production of the closely related 10,11-
dihydroxymagnaporthepyrone 7. Similar compounds were
observed by Vederas and coworkers when the lovasatin non-
aketide synthase (LNKS) was expressed without its cognate ER
encoded by lovC.15
These results can be interpreted if the PKS portion of ACE1
produces the polyunsaturated pyrone 9 (which we name mag-
naporthepyrone, Scheme 2). This compound is then epoxidised
by diﬀerent monooxygenases in either A. oryzae orM. oryzae and
spontaneous hydrolysis of the epoxides results in the observed
diols 6 and 7. Support for this hypothesis comes from the
expression of tenS in A. oryzae where we observed the presence
of prototenellin C 10 (ref. 22) which displays exactly the same
chemical motif as 12,13-dihydroxymagnaporthepyrone 6 – thus
A. oryzaemust possess a monooxidase selective for the terminal
methylbutenyl motif of such precursors. Likewise, M. oryzae is
known to produce diol compounds such as pyriculol 11 (ref. 23)
which must also derive from epoxidation of a polyunsaturated
polyketide followed by hydrolysis. Therefore, M. oryzae must
have a monooxygenase with selectivity for epoxidation of mid-
chain polyenes.
The biosynthesis of 6 and 7 do not require an enoyl reductase
step, consistent with the observation that the ACE1 ER domain
is predicted to be inactive. Coexpression of ACE1 with RAP1,
which encodes a trans-acting ER, changed the biosynthetic
pathway. In the heterologous host A. oryzae, where we con-
structed a single vector to carry both genes, the amide 8 was
produced and compounds derived from 9 were no longer
observed.
Amide 8 is closely related to pyrone 9 and its biosynthesis
can be rationalised by the intervention of the RAP1 ER at the
pentaketide stage of biosynthesis (Scheme 2). Pentaketide
intermediate 12 is recognised by the ACE1 KS domain and
extended to 13, but in the absence of prior enoyl reduction the
next required CMeT step is prevented. Continued chain exten-
sion by an unselective KS then gives the tricarbonyl 14 which
can spontaneously oﬄoad itself from the synthase as the pyrone
9. Alternatively, in the presence of the RAP1 ER, pentaketide 12
is reduced giving a substrate which can be extended by the KS
and then correctly methylated to give 15 before following three
Scheme 2 Deduced biosynthesis of ACE1 products in the presence and absence of RAP1. X ¼ ACE1 ACP domain.
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more extension and processing cycles to give the fully extended
nonaketide 16. Thus the ACE1 CMeT domain appears to display
an additional level of substrate selectivity in blocking correct
chain processing in the absence of 10,11 reduction. Crucially,
however, the KS is unselective and continues to extend the
chain to the tricarbonyl 14 which can be oﬀ-loaded as the
pyrone 9. Thus the lack of selectivity by the KS eﬀectively
removes incorrectly processed chains from the PKS, preventing
its blockage.
Inmany other investigated PKS-NRPS systems the NRPS then
attaches the amino acid to the fully extended polyketide and
either reductively cleaves it,24 or performs a non-reductive Die-
ckmann cyclisation reaction to release an acyl tetramic acid.9 In
this case it appears that tyrosine is used as the amino acid and
attached to the polyketide in the same way as observed in the
cases of pretenellin A 1 and preaspyridone 3. Aer amide
formation, however, the fully elaborated product is probably
reductively released. This could be via 2 electron reduction to
form an aldehyde (as in the classic case of fungal lysine
biosynthesis25) which could be further reduced to a primary
alcohol by an adventitious A. oryzae enzyme, or via double (i.e. 4
electron) reduction catalysed by the NRPS R-domain itself as
observed during the biosynthesis of myxochelin.26
Consistent with this hypothesis is the observation that the
ACE1 terminal-domain has an intact conserved NADPH
binding motif (GXSXXG) and the catalytic triad Ser-Tyr-Lys
more closely resembles ‘reducing’ R-domains than DKC
cyclising domains (see ESI†).24 Qiao et al. predicted a reductive
release for ccsA, the PKS-NRPS gene involved in cytochalasin K
4 biosynthesis in Aspergillus clavatus,27 based on the same
rationale, and the co-expression of ccsA with ccsC by Oikawa
and co-workers led to the production of the amide 17,14 also at
the alcohol oxidation state.
The Oikawa compound 17 diﬀers from 8 in being an octa-
ketide rather than a nonaketide and being evidently con-
structed from phenylalanine rather than tyrosine (Scheme 3). A
further diﬀerence is that 8 is unsaturated between carbons 8
and 9 of the polyketide, whereas 17 is fully saturated at the
corresponding position. Genetic experiments have already
shown that ccsA and ccsC are involved in cytochalasin K 4
biosynthesis, most likely via ketocytochalasin 18.27 Although 17
is unlikely to be a direct precursor of 4, it is probably a shunt
metabolite from the corresponding aldehyde. Vederas, Tang
and coworkers have also recently elucidated that ccsB from the
cytochalasin K biosynthetic pathway is an FAD-dependent oxy-
genase which catalyses (among other reactions) the creation of
the distinctive carbonate moiety of 4.28
The structural similarities between the ccsA/C product 17
and the ACE1/RAP1 product 8 strongly suggest that 8 is also a
shunt metabolite of a cytochalasan-like biosynthetic pathway.13
This is supported by the observation that 8 does not show the
expected biological activity as an avirulence signalling
compound.
To our knowledge, only two other gene clusters have been
correlated with cytochalasan biosynthesis in fungi. These are
the gene clusters for chaetoglobosin A 19 biosynthesis in Peni-
cillium expansum and Chaetomium globosum.29,30 Chaetoglobo-
sin A 19 is biosynthesised from tryptophan and a nonaketide
likely to be almost identical to that of amide 8, except for the
unsaturation between carbons 4 and 5. However, several chae-
toglobosins are also known which are fully saturated at this
position (e.g. chaetoglobosin C 20)31 indicating that amide 8
could include the correct polyketide precursor. Analysis of the
tailoring genes in the ACE1 cluster show that they have more
similarity to the chaetoglobosin biosynthetic genes than those
in the ccs cytochalasin gene cluster (Table S2†).32
Scheme 3 Structural relationships between isolated chemical products of fungal PKS/NRPS and trans-ER proteins and known natural products
and biosynthetic pathways. Although cytochalasans are usually grouped according to the speciﬁc incorporated amino acid, the nature of the
polyketide chain (shown in red) also contributes to their chemical diversity. Numbering for illustrative purposes only. Dashed arrow indicates
biosynthetic relationship and does not indicate a direct precursor/product relationship.
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The nonaketide nature of the amide 8 and the fact that
tyrosine is incorporated, distinguishes the RAP1/ACE1 product
from the ccsA/ccsC compound and mean that the likely ultimate
product of the ACE1 pathway will be a member of the tyrosine-
derived cytochalasans, an example of which is phomop-
sichalasin (also known as diaporthichalasin) 21.33,34 In addition,
the diﬀerences between the ACE1 and ccs gene clusters, such as
the lack of a ccsB homolog, plus additional oxidoreductases
similar to those found in the chaetoglobosin A 19 gene cluster,
indicate that the tailoring of the polyketide backbone is likely to
be more similar to 19, which could arise from a polyketide
identical or very similar to that of 8.
Thus we have shown that heterologous expression is an
eﬀective tool to probe cryptic gene clusters in fungi, which
enables important metabolic relationships to be unravelled. It
is now clear that avirulence signalling between the rice blast
fungus Magnaporthe oryzae and rice is mediated by a natural
product bearing structural similarities to the cytochalasans.
Current and future work in our group is focused on exploring
the enzymatic activities of the proteins encoded by other genes
from the ACE1 biosynthetic cluster to identify the bioactive
compound responsible for avirulence signalling.
Experimental
For construction of vectors, medium conditions, trans-
formation protocols, LCMS methods, NMR data, isotope
feeding experiments and details on biological testing see the
ESI.†
Characterisation of new natural products
12,13-Dihydroxymagnaporthepyrone 6. Isolated as an
amorphous yellow solid (15 mg) and a 1 : 1 mixture of two
diastereoisomers (A and B) by preparative HPLC. 1H NMR (500
MHz acetone-d6): d 1.09 ppm (1.5H, d,
3JHH 6.7, H-14A), 1.11
ppm (1.5H, d, 3JHH 6.3, H-14B), 1.255 (1.5H, s, H-15A), 1.260
(1.5H, s, H-15B), 2.02 (1.5H, s, H-16A), 2.03 (1.5H, s, H-16B), 3.60
(0.5H, q, 3JHH 6.7, H-13A), 3.61 (0.5H, q,
3JHH 6.3, H-13B), 5.39
(1H, d, 3JHH 2.0, H-2A + H-2B), 6.07 (0.5H, d,
3JHH 15.3, H-11A),
6.08 (0.5H, d, 3JHH 15.3, H-11B), 6.20 (1H, d,
3JHH 2.0, H-4A + H-
4B), 6.55 (1H, m, H-10AB), 6.69 (2H, m, H-8AB + H-9AB), 7.09
(1H, d, 3JHH 9.6, H-7AB);
13C NMR (151 MHz acetone-d6): d 12.7
ppm (C-15), 18.1 & 18.3 (C-14), 24.5 & 23.7 (C-16), 74.2 (C-13),
75.8 (C-12), 90.1 (C-2), 99.0 (C-4), 126.8 (C-6), 128.2 (C-8), 129.5 &
129.8 (C-10), 132.5 (C-7), 139.6 & 139.6 (C-9), 142.8 & 143.2 (C-
11), 162.4 (C-3/5), 162.6 (C-5), 163.6 (C-1), 170.7 (C-3); UV/vis
lmax (H2O/MeOH) 273, 362 nm; IR nmax (neat) 3375 brs, 2926,
1685 br s, 1530 cm1; MS (ESI+) m/z (%): 293 (100) [M]H+, 315
(50) [M]Na+; MS (ESI)m/z (%): 291 (100) [MH]; HRMS (ESI+)
calculated [MH2O]H+ 275.1277 found 275.0922; HRMS (ESI)
calculated [M  H] 291.1033 found 291.1238.
10,11-Dihydroxymagnaporthepyrone 7. Isolated 8 mg by
preparative HPLC. 1H NMR (500 MHz acetone-d6): d 1.60 (3H, d,
3JHH 7.2, H-14), 1.65 (3H, s, H-16), 2.00 (3H, s, H-15), 3.93 (1H, d,
3JHH 7.2, H-11), 4.25 (1H, dd,
3JHH 7.7,
3JHH 7.7, H-10), 5.36 (1H,
d, 4JHH 2.0, H-2), 5.50 (1H, q,
3JHH 7.7, H-13), 6.16 (1H, d,
4JHH
2.0, H-4), 6.30 (1H, dd, 3JHH 15.7,
3JHH 15.7, H-9), 6.76 (1H, dd,
3JHH 15.2,
3JHH 15.4, H-8), 7.02 (1H, d,
3JHH 15, H-7);
13C NMR
(151 MHz acetone-d6): d 12.1 ppm (C-14), 12.8 (C-16), 13.2 (C-
15), 73.7 (C-10), 81.0 (C-11), 90.8 (C-2), 99.0 (C-4), 122.1 (C-13),
126.3 (C-6), 126.3 (C-8), 132.2 (C-7), 136.8 (C-12), 142.0 (C-9),
162.0 (C-5), 163.6 (C-1), 170.8 (C-3); UV/vis lmax (H2O/MeOH)
248, 340 nm; MS (ESI+) m/z (%): 293 (100) [M]H+, 315 (50) [M]
Na+; MS (ESI) m/z (%): 291 (100) [M  H]; HRMS (ESI+)
calculated [MH2O]H+ 275.1277 found 275.0922; HRMS (ESI)
calculated [M  H] 291.1033 found 291.1238.
Amide 8. 1H NMR (500 MHz, CDCl3): d 0.92 ppm (d, 3H, J ¼
6.8), 1.35 (m, 2H), 1.51 (m, 2H), 1.56 (s, 3H), 1.72 (d, 3H, J¼ 9.1),
1.74 (s, 3H), 1.95, (t, 2H, J ¼ 7.5), 2.03 (t, 2H, J ¼ 7.1), 2.41 (m,
1H), 2.47 (m, 2H), 2.76 (dd, 1H, J ¼ 7.4, 13.9), 2.81 (dd, 1H, J ¼
7.1, 13.9), 3.31 (d, 1H, J ¼ 17.2), 3.34 (d, 1H, J ¼ 17.2), 3.57 (m,
1H), 3.68 (m, 1H), 4.15 (m, 1H), 4.91 (d, 1H, J¼ 9.3), 5.52 (q, 1H,
J ¼ 6.8), 5.61 (ddd, 1H, J ¼ 14.6, 7.3, 7.3), 6.05 (dd, 1H, J ¼ 14.3,
9.3), 6.08 (dd, 1H, J ¼ 14.6, 9.3), 6.13 (d, 1H, J ¼ 14.6), 6.75 (brd,
2H, J ¼ 8),7.06 (brd, 2H, J ¼ 8), 7.2 (brd, 1H, J ¼ 7.8); 13C NMR
(125 MHz, CDCl3): d 14.6 ppm, 16.6, 18.8, 23.4, 25.4, 29.8, 35.4,
38.8, 41.9, 43.6, 46.4, 51.2, 56.1, 67, 118.1, 128.9, 129.2, 132.0,
133, 133.7, 134.6, 134.8, 135.8, 137.4, 138.1, 157.2, 169, 209.7.
See ESI† for full assignments. HRMS ESI [M]H+: found
482.32649; predicted for C30H43NO4 482.32703.
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